Medicine and Dentistry
Disease
100%
Cardiovascular System
65%
Heart Failure
55%
Neoplasm
51%
Malignant Neoplasm
51%
Cardiovascular Disease
44%
Hepatocellular Carcinoma
44%
Diabetes
44%
Maturity Onset Diabetes of the Young
39%
Infection
38%
Prevalence
37%
Chronic Kidney Disease
35%
Percutaneous Coronary Intervention
34%
Non Small Cell Lung Cancer
31%
Biological Marker
31%
Lung Cancer
31%
Isotopes of Calcium
30%
Chronic Total Occlusion
29%
Drug Therapy
29%
Clinical Trial
29%
Hazard Ratio
29%
Odds Ratio
27%
Symptom
26%
Diagnosis
25%
Blood Pressure
25%
Human Immunodeficiency Virus
25%
Health Care Cost
25%
Myocardial Infarction
25%
Diabetes Mellitus
25%
COVID-19
24%
Meta-Analysis
24%
Placebo
24%
Liver Cirrhosis
24%
Resuscitation
23%
Transplantation
22%
Urinary System
22%
Overall Survival
21%
Kidney Stone
20%
Adverse Event
20%
Body Mass Index
20%
Nephropathy
19%
Breast Cancer
19%
Cohort Analysis
19%
Injury
19%
Apoplexy
19%
Magnetic Resonance Imaging
18%
Clinician
18%
Cardiovascular Risk
18%
Clear Cell Renal Cell Carcinoma
18%
Small Cell Lung Cancer
18%
Liver Transplantation
17%
Radiation Therapy
16%
Atherosclerosis
16%
Oncology
16%
Combination Therapy
16%
In Vitro
16%
Surgery
15%
Systematic Review
15%
Randomized Controlled Trial
15%
Hemodynamic
15%
Exercise
15%
Coronary Artery Disease
14%
Biopsy
14%
Quality of Life
14%
Heart Arrest
14%
Kidney Function
14%
Barrett Esophagus
14%
Patient with Type 2 Diabetes
14%
Pediatrics
14%
Acute Kidney Injury
13%
Revascularization
13%
Coronary Artery
13%
Health Care
13%
Acute Heart Infarction
12%
Heart Failure with Preserved Ejection Fraction
12%
Adipose Tissue
12%
Bleeding
12%
Cancer
12%
Acute Liver Failure
12%
Medicare
12%
Ischemic Heart Disease
12%
Metastatic Carcinoma
12%
Insulin Resistance
12%
Pathophysiology
12%
Statin
12%
Cohort Effect
12%
Recurrent Disease
11%
Epileptic Absence
11%
Acute Coronary Syndrome
11%
Liver Disease
11%
Atrial Fibrillation
11%
Out of Hospital Cardiac Arrest
11%
Metabolic Syndrome
11%
Primary Health Care
11%
Leptin
10%
Obesity
10%
Randomized Clinical Trial
10%
Ejection Fraction
10%
Receptor
10%
Hemodialysis
10%
Biochemistry, Genetics and Molecular Biology
Mouse
98%
Enzyme
39%
Genetics
38%
Eicosanoid Receptor
35%
Low-Density Lipoprotein
32%
Adipocyte
30%
Cancer Cell
28%
Metabolic Pathway
27%
Autophagy
26%
Lipid
24%
Blood Pressure
24%
LDL Receptor
23%
Triglyceride
23%
Insulin Resistance
23%
Promoter Region
22%
Messenger RNA
22%
Gene Expression
22%
Allele
22%
Fibroblast
22%
Oxidoreductase
21%
Kinase
20%
Phosphotransferase
20%
Homeostasis
19%
Transcription Factors
18%
Prevalence
18%
Sterol
18%
Lipoprotein
17%
Amino Acids
17%
Cardiac Muscle Cell
16%
N-Terminus
16%
Transcription
15%
Adenosine Triphosphate
15%
Wild Type
15%
Normal Human
15%
Skeletal Muscle
15%
Adiponectin
14%
Epidermal Growth Factor Receptor
14%
Carcinogenesis
14%
Signal Transduction
13%
Mouse Model
13%
Telomerase
13%
Clinical Trial
13%
Secretion (Process)
13%
Isoform
13%
Glucagon
13%
Surface Property
12%
Cohort Study
12%
Magnetism
12%
Telomere
12%
Reductase
11%
Body Mass
11%
Sterol Regulatory Element-Binding Protein
11%
Glucose Blood Level
11%
Overall Survival
11%
Knockout Mouse
11%
Familial Hypercholesterolemia
11%
Mitochondrion
10%
Leptin
10%
Insulin Sensitivity
10%
Precursor
10%
P53
10%
Cholesterol Synthesis
10%
Methylation
10%
T Cell
10%
Exon
10%
Cell Membrane
9%
C-Terminus
9%
Hepatocyte
9%
Natriuretic Peptide
9%
Blood Level
9%
Binding Protein
9%
Synapsin I
9%
Metabolite
9%
Cholesterol Blood Level
9%
Hyperglycemia
9%
Hypercholesterolemia
9%
Transgenic Mouse
9%
Bile Acid
9%
Tumor Progression
9%
Alpha Oxidation
9%
Tumor Suppressor Gene
8%
Gene Mutation
8%
Monospecific Antibody
8%
Macrophage
8%
HDL-Cholesterol
8%
Cell Proliferation
8%
Binding Site
8%
Stem Cell
8%
Oxidative Stress
8%
Absorption
8%
Tumor Suppressor Protein
8%
Glomerulus Filtration
8%
Androgen Receptor
8%
Dehydrogenase
8%
Hypertriglyceridemia
8%
Cell Death
8%
Lipogenesis
7%
Very Low-Density Lipoprotein
7%
Heart Ejection Fraction
7%
Human Immunodeficiency Virus
7%
Keyphrases
Confidence Interval
31%
Type 2 Diabetes Mellitus (T2DM)
27%
Heart Failure
24%
Obesity
22%
United States
22%
Diabetes
21%
Liver
20%
Cholesterol
20%
Chronic Kidney Disease
19%
Placebo
19%
Hazard Ratio
19%
Hypertension
18%
Hepatocellular Carcinoma
18%
Low-density Lipoprotein
18%
Insulin
18%
Non-small Cell Lung Cancer (NSCLC)
16%
High Risk
15%
Type 2 Diabetic Patients
15%
Clinical Outcomes
14%
Risk Factors
14%
Percutaneous Coronary Intervention
14%
Cardiovascular Disease
14%
Kidney
14%
COVID-19
13%
Tumor
13%
Type 1 Diabetes Mellitus (T1DM)
13%
Cardiovascular Risk
13%
Chronic Total Occlusion
12%
Low-density Lipoprotein Receptor
12%
Odds Ratio
12%
Lung Cancer
12%
Heart Failure with Preserved Ejection Fraction (HFpEF)
12%
Myocardial Infarction
12%
Cirrhosis
12%
Blood Pressure
11%
Chemotherapy
11%
Overall Survival
11%
Meta-analysis
11%
Clinical Trials
11%
Cardiovascular Outcomes
11%
Autophagy
10%
Coronary Artery Disease
10%
Atherosclerotic Cardiovascular Disease (ASCVD)
10%
Lipoproteins
10%
Glucagon
10%
Adipose Tissue
10%
Liver Transplantation
9%
High-density Lipoprotein Cholesterol (HDL-C)
9%
Small Cell Lung Cancer
9%
Insulin Resistance
9%
Low-density Lipoprotein Cholesterol (LDL-C)
9%
Statins
9%
Sterol Regulatory Element-binding protein-1c (SREBP-1c)
9%
Metabolic Syndrome
9%
T Cells
9%
Older Adults
9%
Hospitalization
9%
Cardiovascular Events
8%
Cardiovascular Mortality
8%
Barrett's Esophagus
8%
Inflammation
8%
Body Mass Index
8%
Patients with Diabetes
8%
Leptin
8%
Randomized Controlled Trial
8%
Monoclonal Antibody
8%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
7%
Adipocyte
7%
Cholesterol Levels
7%
Phase II Trial
7%
Acute Liver Failure
7%
Dallas Heart Study
7%
Systemic Lupus Erythematosus
7%
Metabolism
7%
Hypertension Management
7%
All-cause Mortality
7%
Randomized Clinical Trial
7%
Rheumatoid Arthritis
7%
Na +
7%
Homozygous Familial Hypercholesterolemia (HoFH)
6%
Lung
6%
Hemoglobin A1c (HbA1c)
6%
Patients with Heart Failure
6%
Gene Expression
6%
Complementary DNA (cDNA)
6%
Sterols
6%
Acute Myocardial Infarction
6%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
6%
Acute Coronary Syndrome
6%
Heart Failure Hospitalization
6%
Renal Cell Carcinoma
6%
Hepatocellular Carcinoma Surveillance
6%
Phosphorylation
6%
Randomized Trial
6%
Adiponectin
6%
Overexpression
6%
Adverse Events
6%
Insulin Sensitivity
6%
B Cells
6%
Immune Checkpoint Inhibitors
6%